Inactive Instrument
Sector Northwest Biotherapeutics, Inc OTC Bulletin Board
Stocks
US66737P5017
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.33% | -1.71% | +9.33% | +27.63% | +9.15% | +66.54% | +121.08% | +197.83% | +6,885.71% | 55.63B | |
| +0.82% | +15.05% | +17.24% | +21.84% | +30.38% | +79.52% | +88.67% | -24.97% | - | 52.25B | |
| +1.36% | +0.36% | -2.38% | +6.47% | -4.18% | -14.52% | -14.67% | -60.07% | - | 23.07B | |
| -1.04% | +7.91% | -4.60% | -28.85% | -40.60% | +3.91% | +413.05% | +248.08% | +963.58% | 22.41B | |
| +6.72% | +14.70% | +5.76% | +12.44% | +12.15% | +37.47% | -1.92% | -75.53% | - | 17.32B | |
| +0.60% | +3.81% | +0.85% | +1.78% | -15.22% | +30.68% | -32.21% | -33.75% | +46.88% | 15.94B | |
| +2.89% | +5.51% | +6.45% | +31.88% | +24.96% | +25.42% | +188.41% | +203.94% | +603.98% | 13.77B | |
| -3.35% | +8.96% | +33.99% | +80.47% | +145.74% | +134.32% | +282.61% | +1,354.87% | +524.11% | 13.47B | |
| +4.35% | +11.21% | -5.54% | -4.26% | +11.27% | +33.37% | - | - | - | 12.43B | |
| -0.22% | +1.36% | -0.64% | +0.39% | -11.97% | +70.46% | +131.26% | +410.66% | - | 11.82B | |
| +1.72% | +4.33% | +7.00% | +31.50% | +29.35% | +147.86% | +145.34% | +265.29% | +786.62% | 11.16B | |
| -0.48% | -3.58% | -0.20% | +36.54% | +18.83% | +390.61% | +113.68% | -8.50% | +1,385.69% | 11.11B | |
| -1.20% | +1.89% | -19.53% | -15.50% | -19.90% | -31.99% | +432.70% | +95.94% | +77.12% | 10.87B | |
| +10.74% | +11.03% | -22.02% | -30.80% | -18.50% | +0.16% | +160.91% | +44.70% | - | 9.78B | |
| -0.01% | +0.07% | +13.04% | +27.79% | +22.80% | +55.02% | +188.13% | - | - | 9.76B | |
| +11.81% | +18.34% | +12.82% | +18.02% | +339.90% | +222.59% | +226.22% | -42.77% | - | 9.12B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +38.04% | +257.68% | - | 8.19B | |
| +5.29% | +9.88% | +10.69% | +6.32% | +22.50% | +73.48% | +9.88% | +135.50% | - | 8.16B | |
| +14.36% | +19.55% | -3.45% | -19.27% | +10.83% | +46.56% | +140.36% | -34.59% | - | 7.72B | |
| Average | +2.90% | +3.79% | +3.10% | +10.76% | +29.87% | +72.18% | +146.20% | +172.61% | +1,409.21% | 17.05B | |
| Weighted average by Cap. | +1.80% | +4.38% | +5.55% | +13.97% | +21.89% | +65.82% | +135.54% | +148.57% | +2,888.03% |
- Stock Market
- Stocks
- NWBO Stock
- Stock
- Sector Northwest Biotherapeutics, Inc
Select your edition
All financial news and data tailored to specific country editions
